{"id":8984,"date":"2026-02-16T17:50:02","date_gmt":"2026-02-16T15:50:02","guid":{"rendered":"https:\/\/www.msd.ch\/fr\/?page_id=8984"},"modified":"2026-02-16T17:50:03","modified_gmt":"2026-02-16T15:50:03","slug":"enflonsia-publication-of-clinical-trial-results","status":"publish","type":"page","link":"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/","title":{"rendered":"ENFLONSIA\u00ae &#8211; Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques<\/h1>\n\n\n\n<p>Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">ENFLONSIA\u00ae<\/h2>\n\n\n\n<p>ENFLONSIA\u00ae (clesrovimab), solution injectable en seringue pr\u00e9remplie pour administration intramusculaire.<br>Chaque seringue pr\u00e9remplie contient 105 mg de clesrovimab dans 0.7 ml.<\/p>\n\n\n\n<p>Num\u00e9ro d\u2019autorisation: 70145<\/p>\n\n\n\n<p>Date d\u2019autorisation par Swissmedic: 22 janvier 2026<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><br>\u00c9tudes cliniques<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Protocol MK-1654-004<\/h3>\n\n\n\n<p><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04767373\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Study Details | NCT04767373 | Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) | ClinicalTrials.gov<\/a><br>NCT04767373<\/p>\n\n\n\n<p><strong>Publication:<\/strong><br>Zar HJ, Sim\u00f5es EAF, Madhi SA, Ramilo O, Senders SD, Shepard JS, Laoprasopwattana K, Piedrahita J, Novoa JM, Vargas SL, Dionne M, Jackowska T, Liu E, Ishihara Y, Ikeda K, Zhang Y, Railkar RA, Lutkiewicz J, Vora KA, Zang X, Maas BM, Lee AW, Guerra A, Sinha A; CLEVER (MK-1654-004) Study Group. Clesrovimab for Prevention of RSV Disease in Healthy Infants. N Engl J Med.&nbsp;2025 Oct 2;393(13):1292-1303.&nbsp;doi: 10.1056\/NEJMoa2502984.&nbsp;Epub 2025 Sep 17.<\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Protocol MK-1654-007<\/h3>\n\n\n\n<p><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04938830\" target=\"_blank\" rel=\"noreferrer noopener nofollow\"><\/a><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04938830\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Study Details | NCT04938830 | Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007) | ClinicalTrials.gov<\/a><br>NCT04767373<\/p>\n\n\n\n<p><strong>Publication:<\/strong><br>Zar HJ, Bont LJ, Manzoni P, Mu\u00f1oz FM, Ramilo O, Chen PY, Novoa JM, Ordo\u00f1ez GA, Tsolia M, Tapi\u00e9ro B, Acu\u00f1a-\u00c1vila MI, Castellanos JM, Meyer M, Morioka I, Chen Z, Railkar RA, Zang X, Maas BM, Likos A, Lee AW, Castagnini LA, Sinha A; SMART (MK-1654-007) Study Group. Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease. N Engl J Med. 2025 Oct 2;393(13):1343-1345. doi: 10.1056\/NEJMc2506107. Epub 2025 Sep 17.<\/p>\n\n\n\n<p><sup>CH-RSM-00018, 02\/2026<\/sup><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques Les informations ci-dessous ainsi que les liens correspondant aux donn\u00e9es cliniques r\u00e9pondent aux exigences des articles 71 \u00e0 73 de l\u2019Ordonnance sur les m\u00e9dicaments (Ordonnance sur les m\u00e9dicaments, OM\u00e9d) et compl\u00e8tent les informations publi\u00e9es en lien avec l\u2019autorisation suisse des m\u00e9dicaments correspondants. ENFLONSIA\u00ae ENFLONSIA\u00ae (clesrovimab), solution injectable en seringue pr\u00e9remplie [&hellip;]<\/p>\n","protected":false},"author":974,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"bdl_company_name":[],"bdl_item_external_link":[],"editor_notices":[],"footnotes":""},"class_list":["post-8984","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch<\/title>\n<meta name=\"description\" content=\"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\" \/>\n<meta property=\"og:description\" content=\"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"msd.ch\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-16T15:50:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/\",\"url\":\"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/\",\"name\":\"ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch\",\"isPartOf\":{\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\"},\"datePublished\":\"2026-02-16T15:50:02+00:00\",\"dateModified\":\"2026-02-16T15:50:03+00:00\",\"description\":\"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.msd.ch\/fr\/#website\",\"url\":\"https:\/\/www.msd.ch\/fr\/\",\"name\":\"msd.ch\",\"description\":\"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.msd.ch\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","description":"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/","og_locale":"en_US","og_type":"article","og_title":"ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","og_description":"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.","og_url":"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/","og_site_name":"msd.ch","article_modified_time":"2026-02-16T15:50:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/","url":"https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/","name":"ENFLONSIA\u00ae - Publication des r\u00e9sultats d\u2019\u00e9tudes cliniques - msd.ch","isPartOf":{"@id":"https:\/\/www.msd.ch\/fr\/#website"},"datePublished":"2026-02-16T15:50:02+00:00","dateModified":"2026-02-16T15:50:03+00:00","description":"Publication des r\u00e9sultats des essais cliniques d\u2019ENFLONSIA\u00ae (clesrovimab), autoris\u00e9 par Swissmedic le 22 janvier 2026.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.msd.ch\/fr\/enflonsia-publication-of-clinical-trial-results\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.msd.ch\/fr\/#website","url":"https:\/\/www.msd.ch\/fr\/","name":"msd.ch","description":"MSD recherche et d\u00e9veloppe des m\u00e9dicaments et des vaccins pour sauver des vies et am\u00e9liorer la sant\u00e9 des patients. En Suisse, 1000 employ\u00e9s \u00e0 Lucerne et \u00e0 Zurich s&#039;engagent dans ce sens.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.msd.ch\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/8984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/users\/974"}],"replies":[{"embeddable":true,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/comments?post=8984"}],"version-history":[{"count":4,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/8984\/revisions"}],"predecessor-version":[{"id":8988,"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/pages\/8984\/revisions\/8988"}],"wp:attachment":[{"href":"https:\/\/www.msd.ch\/fr\/wp-json\/wp\/v2\/media?parent=8984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}